It may not improve performance and costs more
Over the last several weeks, authorities in states such as Louisiana, Mississippi, North Carolina and West Virginia have threatened to take legal action against compounding pharmacies making unauthorized versions of Ozempic and Wegovy
But the Federal Food, Drug, and Cosmetic Act contains a critical exception: when a drug appears on the FDAs Drug Shortage List, both 503A and 503B pharmacies may compound copies of that drug to help ensure patient access
"Prior weight-loss intervention" does not mean "patient tried to eat less." Acceptable documentation includes: Prescription records showing 90+ days of orlistat, phentermine-topiramate, or naltrexone-bupropion Enrollment records in a structured weight-loss program (e.g., Weight Watchers, Noom, hospital-based program) with attendance logs Bariatric counseling visit notes from a registered dietitian or behavioral health provider, minimum of four visits over 90 days Self-directed diet and exercise, even if documented in provider notes, does not satisfy step therapy in most eviCore reviews
Anecdotal reports show that women in midlife are losing weight on GLP-1 medications, and stubborn weight gain is a huge issue for many menopausal women
As you consider your options, remember that consistency and support are key